A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis
Conditions: Hyperphosphatemia; End Stage Renal Disease Interventions: Drug: Tenapanor; Drug: Sevelamer Carbonate Sponsor: Ardelyx Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2019 Category: Research Source Type: clinical trials
Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients
Conditions: Maintenance Hemodialysis; Hyperphosphatemia Interventions: Drug: Phosphate-binder intervention; Dietary Supplement: Phosphorus-restricted dietary intervention Sponsors: Chen Jing; Huadong Hospital; Shanghai Tongji Hospital, Tongji University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2019 Category: Research Source Type: clinical trials